617-495-4219
The Project on Managing the Atom will host a conversation with Amb. Marjolijn van Deelen, EU Special Envoy for Non-proliferation and Disarmament, on the EU nuclear non-proliferation strategy, the EU position at the next NPT review conference, the role of the EU in strengthening global nuclear cooperation, and more. Matthew Bunn, James R. Schlesinger Professor of the Practice of Energy, National Security, and Foreign Policy and Co-Principal Investigator of Managing the Atom, will moderate the discussion.Amb. Marjolijn van Deelen assumed the position of EU Special Envoy for Non-proliferation and Disarmament on September 1, 2020. In that capacity, she represents the EU in matters related to weapons of mass destruction as well as conventional export controls and Small Arms and Light Weapons.Before joining the EU External Action Service (EEAS), she headed the Non-proliferation, Disarmament and Nuclear Affairs Division of the Ministry of Foreign Affair
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study
Patient enrollment nears completion in investigational study expanding research of sacroiliac joint dysfunction treatment using a novel therapeutic device.
News provided by
Share this article
Share this article
TAMPA, Fla., March 15, 2021 /PRNewswire/ In the wave of innovative medical technology, PainTEQ, in partnership with Evolve Restorative Center in Santa Rosa, California and Celeri Health in Wilmington, Delaware, quickly nears enrollment completion of their single-arm multicenter prospective study exploring SI joint fusion using PainTEQ s posterior approach.
Enrollment continues for patients who have been treated for SI joint dysfunction using the LinQ™ Sacroiliac Joint Fusion System, a potential new standard of care for patients who have not responded to conservative SI joint treatments. PainTEQ s LinQ is a minimally-invasive treatment for patients with chronic SI joint pain, making it a more attractiv
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Meril Life Sciences unveils bioresorbable scaffold MeRes100Â in India
Meril Life Sciences unveils bioresorbable scaffold MeRes100Â in India
10 March 2021 | News Bioresorbable scaffolds are non-metallic, non-permanent mesh tubes, similar to stents, that dissolve over time after ensuring the previously blocked artery is opened via a routine angioplasty procedure
Source: merillife.com
Meril Life Sciences has announced the launch of its indigenously researched and developed bioresorbable scaffold (BRS) MeRes100 in India. Bioresorbable scaffolds are non-metallic, non-permanent mesh tubes, similar to stents, that dissolve over time after ensuring the previously blocked artery is opened via a routine angioplasty procedure.
This novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, sequential manner to ensure adherence to best clinical practices and continued development of clinical research and l
Meril Life Sciences unveils bioresorbable scaffold MeRes100 in India biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.